Showing results (401-410 of 537) with videos related to

Sort By:
Pageof 54
Headache|February 18, 2021
Systematic review of outcomes and endpoints in preventive migraine clinical trialsJames S McGinley, Carrie R Houts, Tracy K Nishida, et al.
Headache|February 21, 2021
Systematic review of outcomes and endpoints in acute migraine clinical trialsCarrie R Houts, James S McGinley, Tracy K Nishida, et al.
Cephalalgia : an International Journal of Headache|July 29, 2020
Non-invasive vagus nerve stimulation for primary headache: A clinical updateStephen D Silberstein, Hsiangkuo Yuan, Umer Najib, et al.
Headache|December 16, 2020
Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment StudyRichard B Lipton, Dawn C Buse, David W Dodick, et al.
Headache|March 21, 2023
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial dataDavid Kudrow, Rima Dafer, David W Dodick, et al.
The Journal of Headache and Pain|May 21, 2024
Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trialRichard B Lipton, Stephanie J Nahas, Patricia Pozo-Rosich, et al.
Cephalalgia : an International Journal of Headache|March 25, 2022
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studiesHans Christoph Diener, Peter McAllister, Tim P Jürgens, et al.
The Journal of Headache and Pain|March 4, 2020
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) studyDawn C Buse, Michael L Reed, Kristina M Fanning, et al.
Neuromodulation : Journal of the International Neuromodulation Society|February 11, 2016
Long-Term Pain Reduction Does Not Imply Improved Functional Outcome in Patients Treated With Combined Supraorbital and Occipital Nerve Stimulation for Chronic MigraineShannon W Clark, Chengyuan Wu, David W Boorman, et al.
Annals of Neurology|April 8, 2010
Triptan-induced latent sensitization: a possible basis for medication overuse headacheMilena De Felice, Michael H Ossipov, Ruizhong Wang, et al.
Pageof 54